Match!
Rossella Elisei
University of Pisa
358Publications
66H-index
16.2kCitations
Publications 365
Newest
#1Laura ValerioH-Index: 6
#2Valeria BotticiH-Index: 18
Last.Rossella EliseiH-Index: 66
view all 13 authors...
Source
#1Kyeong J. Kim (KU: Korea University)
#2Sin G. Kim (KU: Korea University)
Last.Mingzhao Xing (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 15
view all 23 authors...
Abstract Introduction Conservative active surveillance has been proposed for low-risk papillary thyroid microcarcinoma (PTMC), defined as ≤1.0 cm and lacking clinical aggressive features, but controversy exists with accepting it as not all such PTMCs are uniformly destined for benign prognosis. This study investigated whether BRAF V600E status could further risk stratify PTMC, particularly low-risk PTMC, and can thus help with more accurate case selection for conservative management. Methods Thi...
Source
#1Antonio MatroneH-Index: 7
#2Carla GambaleH-Index: 1
Last.Rossella EliseiH-Index: 66
view all 13 authors...
Abstract Objective: In intermediate risk DTC (IR-DTC) patients, selective use of radioiodine (131-I) for remnant ablation and/or as adjuvant therapy (RRA) is advocated. The recently suggested post-...
Source
#1Antonio Matrone (UniPi: University of Pisa)H-Index: 7
#2Giovanni Ceccarini (UniPi: University of Pisa)H-Index: 20
Last.Rossella Elisei (UniPi: University of Pisa)H-Index: 66
view all 13 authors...
Source
#1Antonio MatroneH-Index: 7
#2Liborio TorregrossaH-Index: 17
Last.Rossella EliseiH-Index: 66
view all 15 authors...
The diagnosis of the primary origin of metastases to the thyroid gland is not easy, in particular in case of concomitant lung adenocarcinoma which shares several immunophenotypical features. Although rare, these tumors should be completely characterized in order to set up specific therapies. This is the case of a 64-years-old woman referred to our institution for a very advanced neoplastic disease diagnosed both as poorly differentiated/anaplastic thyroid cancer (PDTC/ATC) for the huge involveme...
Source
2 CitationsSource
#2Rosa LaurettaH-Index: 3
Last.Rossella EliseiH-Index: 66
view all 9 authors...
Background: The concomitant presence of papillary thyroid cancer (PTC) and medullary TC (MTC) is rare. In this multicentric study, we documented the epidemiological characteristics, disease conditions and clinical outcome of patients with simultaneous MTC/PTC. Methods: We collected data of patients with concomitant MTC/PTC at 14 Italian referral centers. Results: In total, 183 patients were enrolled. Diagnosis was mostly based on cytological examination (n = 58, 32%). At diagnosis, in the majori...
Source
#1Raffaele CiampiH-Index: 22
#2Cristina RomeiH-Index: 37
Last.Rossella EliseiH-Index: 66
view all 12 authors...
Summary Sporadic Medullary Thyroid Carcinoma (sMTC) is a rare but aggressive thyroid tumor. RET and RAS genes are present in about 50%–80% of cases, but most of the remaining cases are still orphan of a genetic driver. We studied the largest series of sMTC by deep sequencing to define the mutational landscape. With this methodology we greatly reduced the number of RET- or RAS-negative cases and we confirmed the central role of RET and RAS mutations. Moreover, we highlighted the bad prognostic ro...
Source
#1Eleonora MolinaroH-Index: 33
#2David ViolaH-Index: 16
Last.Rossella EliseiH-Index: 66
view all 11 authors...
Background. The tyrosine kinase inhibitors (TKIs) are indicated for the treatment of locally advanced or metastatic progressive thyroid carcinoma (CDT), refractory to radioactive iodine. The following report describes the efficacy of lenvatinib administered through a nose-gastric tube (SNG) in a patient affected with a poorly differentiated thyroid carcinoma (PDTC) which determined a stenosis of the esophagus. Material and Methods. A patient was followed up for papillary thyroid carcinoma follic...
Source
#1Rossella EliseiH-Index: 66
#2Alessia TacitoH-Index: 8
Last.Cristina RomeiH-Index: 37
view all 16 authors...
Background: Pathogenic germline mutations affecting the RET proto-oncogene underlie the development of hereditary medullary thyroid carcinoma (MTC). The aims of this study were to evaluate the prevalence of germline RET mutations in a large series of MTC, collected over the last 25 years, and to reappraise their clinical significance. Methods: We performed RET genetic screening in 2031 Italian subjects: patients who presented with sporadic (n = 1264) or hereditary (n = 117) MTC, plus 650 relativ...
1 CitationsSource
12345678910